Endocyte, Inc. News
Dow Trades Lower on Rates Fears, Tech Shares Sink Nasdaq
Stocks fall sharply on Thursday after a hawkish set of minutes from last month's Federal Reserve meeting cements the case for near-term interest rate hikes.
Novartis Snaps up Prostate Cancer Treatment with Endocyte Deal
The Swiss drugmaker will pay $2.1 billion for Endocyte, justifying the Nasdaq-listed biotech's pivot to prostate treatment last year.
Facebook, Fed Minutes, AmEx, PayPal and Endocyte - 5 Things You Must Know
U.S. stock futures decline after a hawkish set of minutes from last month's Federal Reserve meeting; American Express, PayPal and Travelers report earnings; Facebook believes hack was done by spammers, says a report; Novartis to buy Endocyte for $2.1 billion.
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.